ACE2 and acute respiratory distress syndrome: A recombinant version of the catalytic ectodomain of human ACE2 (rhACE2, GSK2586881) attenuated arterial hypoxemia in a piglet model of lipopolysaccharide-induced ALI [24] and was well-tolerated when administered to healthy human volunteers [25].